挽救性前列腺根治术毒性是否与初始前列腺癌治疗方式相关?
这项多中心回顾性研究比较了局部治疗后与放疗后挽救性前列腺根治术的毒性和肿瘤学结局。放疗后挽救性手术的30天Clavien-Dindo I-IV并发症率显著更高(34% vs 5%,p<0.001),12个月控尿率更差(49% vs 83%无尿垫),但两组3年生化复发率无显著差异(32% vs 35%,p=0.76)。
要点
- 放疗后挽救性前列腺根治术的30天并发症率显著高于局部治疗后(34% vs 5%)。
- 局部治疗后12个月控尿率显著优于放疗后(83% vs 49%无尿垫)。
- 两组3年生化复发率无显著差异(35% vs 32%,p=0.76)。
核心结论
- 挽救性前列腺根治术的围手术期并发症和长期控尿恢复取决于初始前列腺癌治疗方式,局部治疗后并发症更低、控尿更好。
研究设计与样本
- 多中心回顾性研究,纳入2007年4月至2018年9月4个高容量手术中心的185例挽救性前列腺根治术患者,其中局部治疗后95例、放疗后90例,中位随访29.5个月。
主要发现
- 放疗后挽救性手术的30天Clavien-Dindo I-IV并发症率为34%,显著高于局部治疗后的5%(p<0.001)。
- 术后12个月,局部治疗后无尿垫控尿率为83%,显著优于放疗后的49%;两组勃起功能率相似(14% vs 11%)。
- 放疗后挽救性手术者的肿瘤分期和分级更高,切缘阳性率更高(37% vs 13%,p=0.001)。
- 局部治疗后3年生化复发率为35%,放疗后为32%(p=0.76)。
- 多因素分析中,局部治疗后挽救性手术与更高的生化复发风险相关(HR 0.36,95%CI 0.16-0.82,p=0.02)。
临床怎么用
- 对于初始接受局部治疗的患者,挽救性前列腺根治术的围手术期并发症和控尿结局可能优于放疗后挽救性手术。
- 放疗后挽救性手术者肿瘤分期分级更高、切缘阳性率更高,术前评估需更充分。
局限性
- 回顾性研究设计,可能存在选择偏倚。
- 样本量有限(185例),来自4个高容量中心,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the toxicity profile and oncological outcome of salvage radical prostatectomy following focal therapy versus salvage radical prostatectomy after radiation therapies (external beam radiation therapy or brachytherapy). MATERIALS AND METHODS: Data concerning all men undergoing salvage radical prostatectomy for recurrent prostate cancer after either focal therapy, external beam radiation therapy or brachytherapy were retrospectively collected from 4 high volume surgical centers. The primary outcome measure of the study was toxicity of salvage radical prostatectomy characterized by any 30-day postoperative Clavien-Dindo complication rate, 12-month continence rate and 12-month potency rate. The secondary outcome was oncological outcome after salvage radical prostatectomy including positive margin rate and 12-month biochemical recurrence rate. Biochemical recurrence was estimated using Kaplan-Meier methods and significant differences were calculated using a log rank test. Median followup was 29.5 months. RESULTS: Between April 2007 and September 2018, 185 patients underwent salvage radical prostatectomy of whom 95 had salvage radical prostatectomy after focal therapy and 90 had salvage radical prostatectomy after radiation therapy (external beam radiation therapy or brachytherapy). Salvage radical prostatectomy after radiation therapy was associated with a significantly higher 30-day Clavien-Dindo I-IV complication rate (34% vs 5%, p <0.001). At 12 months following surgery, patients undergoing salvage radical prostatectomy after focal therapy had significantly better continence (83% pad-free vs 49%) while potency outcomes were similar (14% vs 11%). Men undergoing salvage radical prostatectomy after radiation therapy had a significantly higher stage and grade of disease together with a higher positive surgical margin rate (37% vs 13%, p=0.001). The 3-year biochemical recurrence after focal therapy was 35% compared to 32% after radiation therapy (p=0.76). In multivariable analysis, men undergoing salvage radical prostatectomy after focal therapy experienced a higher risk of biochemical recurrence (HR 0.36, 95% CI 0.16-0.82, p=0.02). CONCLUSIONS: This multicenter study demonstrates the toxicity of salvage radical prostatectomy in terms of perioperative complications and long-term urinary continence recovery is dependent on initial primary prostate cancer therapy received with men undergoing salvage radical prostatectomy after focal therapy experiencing lower postoperative complication rates and better urinary continence outcomes.
引用
- Ribeiro L, Stonier T, Stroman L, et al. Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received? J Urol. 2020. PMID: 33021441. doi:10.1097/JU.0000000000001382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。